From the first hand-held vagus nerve stimulator for episodic cluster headache to a TMS therapy system for depression, we highlight 5 new technologies.
Five new technologies in neurology include the first hand-held vagus nerve stimulator for episodic cluster headache, an FDA-authorized genetic health risks test, a neurosurgery tracking system, a TMS therapy system to treat depression, and a rehabilitation assist robot for patients recovering from stroke and other neurological conditions.
1. Silberstein SD, et al, for the ACT1 Study Group. Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study. Headache. 2016;56:1317-1332.
2. Carpenter LL, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012 Jul;29(7):587-596.
gammaCore. Website link.
First non-invasive, hand-held vagus nerve stimulator applied at the neck for treatment of episodic cluster headache
23andMe Personal Genome Service Genetic Health Risk Tests. Website link.
StealthStation S8 Neurosurgery System. Website link.
Includes 3D cameras, electromagnetic sensors for tracking location of tools, related tracking algorithms, software for data processing, can merge data from different imaging sources to assist guidance
Neurostar. Website link.
Cleared by FDA in April 2017 for treating major depressive disorder (MDD) in patients with inadequate response to at least one antidepressant
Welwalk WW-1000. press release.